An open label, single sequence, repeat dose study to investigate the effects of GSK 189075 [remogliflozin etabonate] on the pharmacokinetics of an oral contraceptive pill [ethinylestradiol/norethisterone] when coadministered to healthy female volunteers.

Trial Profile

An open label, single sequence, repeat dose study to investigate the effects of GSK 189075 [remogliflozin etabonate] on the pharmacokinetics of an oral contraceptive pill [ethinylestradiol/norethisterone] when coadministered to healthy female volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Jun 2012

At a glance

  • Drugs Ethinylestradiol/norethisterone; Remogliflozin etabonate
  • Indications Pregnancy
  • Focus Pharmacokinetics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 03 Feb 2010 Actual end date (Apr 2008) added as reported by ClinicalTrials.gov.
    • 03 Feb 2010 Actual patient number (22) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top